Skip to content

Effects of different concentrations of ropivacaine on ultrasound-guided single-sacral nerve block in the treatment of knee angioplasty

Effects of different concentrations of ropivacaine on ultrasound-guided single-sacral nerve block in the treatment of knee angioplasty

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900020623
Enrollment
Unknown
Registered
2019-01-10
Start date
2019-01-07
Completion date
Unknown
Last updated
2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain after knee arthroscopy

Interventions

M group:No nerve block
SL group:Ultrasound-guided saphenous nerve block with 0.375% ropivacaine after operation
SM group:Ultrasound-guided saphenous nerve block with 0.5% ropivacaine after operation
SM group:Ultrasound-guided saphenous nerve block with 0.75% ropivacaine after operation

Sponsors

The First Affiliated Hospital of Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 65 years old; 2. ASA I~II level; 3. BMI 18~28kg/m2; 4. Patients undergoing elective knee arthroscopy.

Exclusion criteria

Exclusion criteria: 1. Pregnant or lactating woman; 2. History of allergy to local anesthetics; 3. mental and neurological diseases; 4. Diabetes and peripheral neuropathy or injury; 5. Patients with systemic diseases such as severe liver and kidney, heart and lung; 6. History of chronic pain; 7. Recent use of painkillers, hormones, and drug abuse history.

Design outcomes

Primary

MeasureTime frame
VAS pain score at different time points after operation;Postoperative morphine consumption;Time to start getting out of bed;Quadric muscle strength at different time points after operation;

Secondary

MeasureTime frame
Vital signs (mean arterial pressure, heart rate and respiratory rate) at different time points after operation;Postoperative adverse reactions (nausea and vomiting, urinary retention, itching) at different time points after operation;

Countries

China

Contacts

Public ContactJiehao Sun

The First Affiliated Hospital of Wenzhou Medical University

linwendong2000@163.com+86 13819705490

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026